Cite
HARVARD Citation
Lavin, M. et al. (n.d.). Lenalidomide as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy. Journal of thrombosis and haemostasis. pp. 1200-1205. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lavin, M. et al. (n.d.). Lenalidomide as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy. Journal of thrombosis and haemostasis. pp. 1200-1205. [Online].